Medicine News and Research

RSS

China Aoxing submits an NDA to the China SFDA for its Codeine Phosphate

China Aoxing Pharmaceutical Company, Inc. (OTCBB: CAXG) ("China Aoxing"), a pharmaceutical company specializing in research, development, manufacturing and marketing of narcotic and pain-management products, today announced that it has submitted a new drug application (NDA) to the China State Food and Drug Administration (SFDA) for its Codeine Phosphate, a compound oral solution for the treatment of acute moderate to severe cough.

3 Sep 2009

RCN to partner with University of Illinois Medical Center for Fall Rush campaign

RCN Corporation, a leading provider of all-digital and high definition video, high-speed internet, and premium voice services to residential and small-medium business customers, as well as high-capacity transport services to carrier and large enterprise customers, announced today it will partner with the University of Illinois Medical Center as part of its Fall Rush campaign.

3 Sep 2009

Reliable and relevant information needed to rein in the costs of federal health-care programs, says study

For economists and policy-makers to understand the true value of the costs and savings of preventive health programs for chronic disease, the Congressional Budget Office (CBO) should incorporate long-term clinical outcomes data and look beyond the 10-year window when making cost estimates, says a team of University of Chicago researchers in today's issue of Health Affairs.

3 Sep 2009

First-quarter fiscal 2010 results announced by Peregrine Pharmaceuticals

Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today announced financial results for the first quarter of fiscal year (FY) 2010 ended July 31, 2009. Total revenues for the first quarter of FY 2010 increased 345% to $6,750,000, compared to $1,517,000 for the comparable prior year quarter. This increase was primarily generated from increased government contract revenue and from increased sales by Avid Bioservices, the company's wholly owned contract manufacturing subsidiary.

3 Sep 2009

Umass Medical School implements translational research solution

Recombinant Data Corp., a healthcare data warehousing and clinical intelligence solutions provider, today announced that it has implemented a translational research solution at the University of Massachusetts Medical School.

3 Sep 2009

THNN's Vice President to supervise the clinical research applications of SUPER MEAL RX

THNN Inc. (Transformation Health Nutrition Naturals Inc.) enthusiastically announces the appointment of Dr. Thoger Malmstrom to the position of Vice President for Nutritional Wellness Applications.

3 Sep 2009

CRT-D implants for treating sudden cardiac death

Electrophysiologists Robert Stevenson, MD, and Jeffrey L. Williams, MD, MS, FACC, are safely implanting cardiac resynchronization therapy defibrillators in the Good Samaritan Hospital (GSH) Cardiology (Heart Failure) Program.

3 Sep 2009

President Obama urged to make medical liability a more central component of health care reform

The American College of Surgeons applauds Democrats - led by House Majority Leader Steny Hoyer (D-MD) - for recognizing the need for Congress to address medical liability reform as part of the overall health care reform bill currently under consideration.

3 Sep 2009

Study reports a potential new investigational therapy for skin cancer

A study published today in the New England Journal of Medicine reports a potential new investigational therapy for advanced and metastatic basal cell skin cancer tested at the Virginia G. Piper Cancer Center at Scottsdale Healthcare and other sites appears to demonstrate tumor shrinkage and limited side effects in patients.

3 Sep 2009

Two 2008 drug approval reports highlight Ceplene benefits

EpiCept Corporation today announced that Ceplene (histamine dihydrochloride) has been highlighted in two separate reports issued recently reviewing 2008 drug approvals in the European Union.

3 Sep 2009

IsoFlow Infusion catheter allows physicians to increase drug concentrations at targeted sites

Vascular Designs, a medical device company, today announced that its IsoFlow(TM) infusion catheter has secured 510(k) marketing clearance by the U.S. Food and Drug Administration (FDA) for the direct delivery of medications into highly targeted areas. An important application of IsoFlow may be in the treatment of cancer.

3 Sep 2009

Resident duty-hour reform increases medical complications in teaching hospitals

A new study finds a 2003 reform of the length of resident on-duty hours has led to an increase in the rate of perioperative (the span of all three phases of surgery: before, during and after) complications for patients treated for hip fractures.

3 Sep 2009

CORD I phase III clinical trial results of XIAFLEX published

Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced that The New England Journal of Medicine (NEJM) has published in its September 3rd edition, the Company's pivotal CORD I Phase III clinical trial of XIAFLEX (collagenase clostridium histolyticum) a novel, first-in-class, biologic for the nonsurgical treatment of Dupuytren's contracture.

3 Sep 2009

Kane Biotech announces Harvard Medical School's research publication on its DispersinB product

Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development of products that prevent and disperse microbial biofilms is pleased to announce a recent research publication by Harvard Medical School on their finding of DispersinB® enzyme specific substrate in Acinetobacter baumannii (A. baumannii).

3 Sep 2009

Bio-Reference Laboratories reports third-quarter fiscal 2009 revenues

Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) (Except for Per Share Data or where otherwise noted, numbers are in thousands) announced that the Company recorded current quarter revenues of $97,424, the best ever quarter in terms of revenues in corporate history and an increase of more than 25% over the $77,776 recorded in the third quarter, fiscal year 2008.

3 Sep 2009

Mosquito screens prevent malaria

Trials of a screen-based malaria prevention programme in 500 homes in The Gambia, Africa, have led to a 50 per cent reduction in malaria transmission and anaemia in children. A child dies from malaria in Africa every 30 seconds and infection can lead to an increased risk of anaemia, which can also prove fatal. Yet to date, screens have often been ignored in favour of using drugs and insecticides.

3 Sep 2009

Study identifies key compound that quickens recovery from life-threatening blood cell shortages

A key compound resupplies bone marrow with fast-acting stem cells that can more quickly rekindle blood cell production, according to a study published online today in the journal Blood. While the study was in mice, in the study authors say it has the potential to increase survival among patients with life-threatening blood cell shortages.

3 Sep 2009

IPC The Hospitalist Company acquires Hospital Medicine Associates

IPC The Hospitalist Company, Inc., a leading national hospitalist physician group practice company, announced today that it has acquired Hospital Medicine Associates, P.C. (HMA).

3 Sep 2009

Riverside Medical Center adds two more doctors

Internal Medicine Physician Rahul Deepankar, M.D. and Pediatrician Jane Kapral, M.D. are the two newest team members to join the Riverside Medical Center - West Campus in Coal City.

3 Sep 2009

Alternative device for increased specificity of bronchoscopic lung cancer detection

Research published in the September 2009 issue of the Journal of Thoracic Oncology has found that narrow-band imaging bronchoscopy increases the specificity of bronchoscopic early lung cancer detection and can serve as an alternative detection device.

3 Sep 2009

Medicine News and Research

China Aoxing submits an NDA to the China SFDA for its Codeine Phosphate

RCN to partner with University of Illinois Medical Center for Fall Rush campaign

Reliable and relevant information needed to rein in the costs of federal health-care programs, says study

First-quarter fiscal 2010 results announced by Peregrine Pharmaceuticals

Umass Medical School implements translational research solution

THNN's Vice President to supervise the clinical research applications of SUPER MEAL RX

CRT-D implants for treating sudden cardiac death

President Obama urged to make medical liability a more central component of health care reform

Study reports a potential new investigational therapy for skin cancer

Two 2008 drug approval reports highlight Ceplene benefits

IsoFlow Infusion catheter allows physicians to increase drug concentrations at targeted sites

Resident duty-hour reform increases medical complications in teaching hospitals

CORD I phase III clinical trial results of XIAFLEX published

Kane Biotech announces Harvard Medical School's research publication on its DispersinB product

Bio-Reference Laboratories reports third-quarter fiscal 2009 revenues

Mosquito screens prevent malaria

Study identifies key compound that quickens recovery from life-threatening blood cell shortages

IPC The Hospitalist Company acquires Hospital Medicine Associates

Riverside Medical Center adds two more doctors

Alternative device for increased specificity of bronchoscopic lung cancer detection

Everything there is to know about biosimilars eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News